Document is current

Any future updates will be listed below

Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12969-021-00593-3

Published Online: 2021-08-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark